Recent Articles

Key Publications

Immuno-Oncology 

Ranked in Biomaterials Science Most Popular 30 Articles in 2020:

Shukla S., Wang C., Beiss V., Cai H., Washington T., Murray A., Gong X., Zhao Z., Masarapu H., Zlotnik A., Fiering S., and Steinmetz N.F. (2020) The unique potency of Cowpea mosaic virus (CPMV) in situ cancer vaccine. Biomater. Sci., 2020, 8, 5489-5503.

Wang C. and Steinmetz N.F. (2020) A Combination of Cowpea mosaic virus and Immune Checkpoint Therapy Synergistically Improves Therapeutic Efficacy in Three Tumor Models. Advanced Functional Materials, accepted. PMID: pending, PMCID: pending.

Wang C.*, Fiering S., Steinmetz N.F. (2019) Cowpea Mosaic Virus Promotes Anti-Tumor Activity and Immune Memory in a Mouse Ovarian Tumor Model. Advanced Therapeutics. 1900003. PMID: pending, PMCID: pending (NIHMS 1066974).

Immuno-Oncology - Veterinary

Vaccine

Lee P.W., Shukla S., Wallat J.D., Danda C., Steinmetz N.F., Maia J., Pokorski J.K. (2017) Biodegradable Viral Nanoparticle/Polymer Implants Prepared via Melt-Processing. ACS Nano, 11,8777-8789.

Grants

Mosaic’s IO and VAX technology has been developed over the past ten years by the Principal Investigators and Co-Founders of Mosaic: Drs. Steinmetz, Pokorski, and Fiering. The technology development has been supported through numerous federal research grants, including NIH, NSF, and CDMRP as well as private foundations, such as the American Cancer Society, Susan G Komen, and American Heart Association totaling $21 Million.